Trial Profile
Evaluation of the efficacy of atorvastatin in patients with CKD
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 28 Jul 2015
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacodynamics
- 24 Jan 2013 New trial record
- 07 Jan 2013 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.